UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 21, 2019
Accession Number:
Submission Type:
CIK: 0001588972
Company Name: Recro Pharma, Inc.
File Number: 333-229734